ALLR · Company research
Allarity Therapeutics, Inc. Common Stock (ALLR): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
19records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Allarity Therapeutics (ALLR) withholds 14,613 shares for taxes as Graff's stock grant vests. - Stock Titan | Allarity Therapeutics (ALLR) withholds 14,613 shares for taxes as Graff's stock grant vests. Stock Titan | View source ↗ | Stock Titan | Oct 9, 2026 | neutral | 0 | 0.6 |
| Here's Why Allarity Therapeutics, Inc. (ALLR) Is a Great 'Buy the Bottom' Stock Now | Allarity Therapeutics (ALLR) has formed a hammer chart pattern, suggesting potential trend reversal after recent declines. The stock is supported by strong analyst agreement on raising earnings estimates, with consensus EPS estimates up 13% over the last 30 days. ALLR holds a Zacks Rank #2 (Buy), placing it in the top 20% of rated stocks. | View source ↗ | Zacks Investment Research | Oct 9, 2026 | bullish | 1 | 1 |
| Here's Why Allarity Therapeutics, Inc. (ALLR) Is a Great 'Buy the Bottom' Stock Now | Allarity Therapeutics (ALLR) has formed a hammer chart pattern, suggesting potential trend reversal after recent declines. The stock is supported by strong analyst agreement on raising earnings estimates, with consensus EPS estimates up 13% over the last 30 days. ALLR holds a Zacks Rank #2 (Buy), placing it in the top 20% of rated stocks. | View source ↗ | Zacks Investment Research | Oct 9, 2026 | bullish | 1 | 1 |
| Here's Why Allarity Therapeutics, Inc. (ALLR) Is a Great 'Buy the Bottom' Stock Now - Yahoo Finance | Here's Why Allarity Therapeutics, Inc. (ALLR) Is a Great 'Buy the Bottom' Stock Now Yahoo Finance | View source ↗ | Yahoo Finance | Oct 9, 2026 | neutral | 0 | 0.6 |
| Allarity Therapeutics, Inc. (ALLR) Stock Price, News, Quote & History - Yahoo! Finance Canada | Allarity Therapeutics, Inc. (ALLR) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 6, 2026 | neutral | 0 | 0.6 |
| ALLR Q2 2026 Earnings: Narrower-Than-Expected Loss, but Shares Slip - Earnings Recovery Stocks - https://www.dars.gov.et/ | ALLR Q2 2026 Earnings: Narrower-Than-Expected Loss, but Shares Slip - Earnings Recovery Stocks https://www.dars.gov.et/ | View source ↗ | https://www.dars.gov.et/ | Oct 1, 2026 | neutral | 0 | 0.6 |
| Patents and a certified lab help Allarity retain sole control of its cancer test - Stock Titan | Patents and a certified lab help Allarity retain sole control of its cancer test Stock Titan | View source ↗ | Stock Titan | Sep 30, 2026 | neutral | 0 | 0.6 |
| About 300 proteins involved in tumor signaling can now be studied at Allarity’s lab. - Stock Titan | About 300 proteins involved in tumor signaling can now be studied at Allarity’s lab. Stock Titan | View source ↗ | Stock Titan | Sep 28, 2026 | neutral | 0 | 0.6 |
| Allarity Therapeutics (ALLR) Stock Analysis Report | Financials & Insights - Benzinga | Allarity Therapeutics (ALLR) Stock Analysis Report | Financials & Insights Benzinga | View source ↗ | Benzinga | Sep 27, 2026 | neutral | 0 | 0.6 |
| Allarity Therapeutics (ALLR) Gains 4.31% to $1.21, Pressing Toward Resistance at $1.27 - Volatility Term Structure - dars.gov.et | Allarity Therapeutics (ALLR) Gains 4.31% to $1.21, Pressing Toward Resistance at $1.27 - Volatility Term Structure dars.gov.et | View source ↗ | dars.gov.et | Sep 20, 2026 | neutral | 0 | 0.6 |
| A cancer test to find patients likely to benefit gets a Japan patent - Stock Titan | A cancer test to find patients likely to benefit gets a Japan patent Stock Titan | View source ↗ | Stock Titan | Sep 15, 2026 | neutral | 0 | 0.6 |
| Allarity Therapeutics Inc (ALLR) Peer Comparison – Compare with Others - Value Research | Allarity Therapeutics Inc (ALLR) Peer Comparison – Compare with Others Value Research | View source ↗ | Value Research | Aug 31, 2026 | neutral | 0 | 0.6 |
| Is Allarity Therapeutics, Inc. (ALLR) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance | Is Allarity Therapeutics, Inc. (ALLR) Stock Outpacing Its Medical Peers This Year? Yahoo Finance | View source ↗ | Yahoo Finance | Jul 6, 2026 | neutral | 0 | 0.6 |
| ALLR Forecast — Price Target — Prediction for 2027 - TradingView | ALLR Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 26, 2026 | neutral | 0 | 0.6 |
| Is Allarity Therapeutics, Inc. (ALLR) Outperforming Other Medical Stocks This Year? - Yahoo Finance | Is Allarity Therapeutics, Inc. (ALLR) Outperforming Other Medical Stocks This Year? Yahoo Finance | View source ↗ | Yahoo Finance | Jun 19, 2026 | neutral | 0 | 0.6 |
| Allarity Therapeutics (ALLR) Institutional Ownership 2026 $ALLR - MarketBeat | Allarity Therapeutics (ALLR) Institutional Ownership 2026 $ALLR MarketBeat | View source ↗ | MarketBeat | May 14, 2026 | neutral | 0 | 0.6 |
| Allarity Therapeutics Signs Common Stock Purchase Agreement With Tumim Stone Capital - TradingView | Allarity Therapeutics Signs Common Stock Purchase Agreement With Tumim Stone Capital TradingView | View source ↗ | TradingView | Jan 29, 2026 | neutral | 0 | 0.6 |
| symbol__ Stock Quote Price and Forecast - CNN | symbol__ Stock Quote Price and Forecast CNN | View source ↗ | CNN | Mar 12, 2024 | neutral | 0 | 0.6 |
| Allarity Therapeutics, Inc. (ALLR) - Zacks Investment Research | Allarity Therapeutics, Inc. (ALLR) Zacks Investment Research | View source ↗ | Zacks Investment Research | Dec 24, 2021 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.